1.39
price up icon1.46%   0.02
after-market アフターアワーズ: 1.41 0.02 +1.44%
loading
前日終値:
$1.37
開ける:
$1.36
24時間の取引高:
1.67M
Relative Volume:
0.60
時価総額:
$98.84M
収益:
$391.70K
当期純損益:
$-52.34M
株価収益率:
-1.8533
EPS:
-0.75
ネットキャッシュフロー:
$-45.92M
1週間 パフォーマンス:
-14.72%
1か月 パフォーマンス:
+6.92%
6か月 パフォーマンス:
+324.95%
1年 パフォーマンス:
+23.01%
1日の値動き範囲:
Value
$1.34
$1.46
1週間の範囲:
Value
$1.34
$1.73
52週間の値動き範囲:
Value
$0.2425
$2.01

Ovid Therapeutics Inc Stock (OVID) Company Profile

Name
名前
Ovid Therapeutics Inc
Name
セクター
Healthcare (1135)
Name
電話
212-776-4381
Name
住所
441 NINTH AVENUE, 14TH FLOOR, NEW YORK, NY
Name
職員
23
Name
Twitter
@OvidRx
Name
次回の収益日
2024-11-04
Name
最新のSEC提出書
Name
OVID's Discussions on Twitter

OVID を他の銘柄と比較する

株式 価格 時価総額 収益 当期純利益 現金流量 EPS
Biotechnology icon
OVID
Ovid Therapeutics Inc
1.39 97.42M 391.70K -52.34M -45.92M -0.75
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
425.57 107.66B 11.39B 3.64B 3.50B 13.99
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
651.80 68.74B 14.25B 4.58B 3.88B 41.77
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
456.04 58.93B 3.21B 43.57M 221.36M 0.2405
Biotechnology icon
ARGX
Argen X Se Adr
818.50 50.51B 3.06B 1.28B 447.35M 19.67
Biotechnology icon
INSM
Insmed Inc
189.60 41.29B 447.02M -1.18B -868.57M -6.1812

Ovid Therapeutics Inc Stock (OVID) Upgrades & Downgrades

日付 アクション アナリスト 評価の変更
2025-10-09 開始されました Oppenheimer Outperform
2025-08-08 再開されました B. Riley Securities Buy
2024-06-18 ダウングレード Oppenheimer Outperform → Perform
2024-04-30 開始されました B. Riley Securities Buy
2024-04-29 開始されました H.C. Wainwright Buy
2024-04-05 開始されました Wedbush Outperform
2023-12-21 開始されました BTIG Research Buy
2023-10-13 開始されました Oppenheimer Outperform
2021-04-20 ダウングレード Cantor Fitzgerald Buy → Neutral
2021-03-03 ダウングレード RBC Capital Mkts Outperform → Sector Perform
2020-12-02 ダウングレード Citigroup Buy → Neutral
2020-12-02 ダウングレード JMP Securities Mkt Outperform → Mkt Perform
2019-09-04 開始されました RBC Capital Mkts Outperform
2018-04-20 開始されました Ladenburg Thalmann Buy
すべてを表示

Ovid Therapeutics Inc (OVID) 最新ニュース

pulisher
12:51 PM

Can trapped investors hope for a rebound in Ovid Therapeutics Inc.2025 Technical Overview & Safe Capital Growth Tips - newser.com

12:51 PM
pulisher
02:53 AM

How Ovid Therapeutics Inc. (1OT) stock correlates with oil markets2025 Price Action Summary & Fast Entry and Exit Trade Plans - newser.com

02:53 AM
pulisher
Nov 01, 2025

Combining machine learning predictions for Ovid Therapeutics Inc.Watch List & Technical Buy Zone Confirmation - newser.com

Nov 01, 2025
pulisher
Nov 01, 2025

Visual analytics tools that track Ovid Therapeutics Inc. performanceM&A Rumor & Risk Managed Investment Entry Signals - newser.com

Nov 01, 2025
pulisher
Nov 01, 2025

Is Ovid Therapeutics Inc. stock a safe haven assetWeekly Gains Summary & Scalable Portfolio Growth Methods - newser.com

Nov 01, 2025
pulisher
Oct 31, 2025

Long term hold vs stop loss in Ovid Therapeutics Inc.July 2025 Spike Watch & Real-Time Volume Spike Alerts - newser.com

Oct 31, 2025
pulisher
Oct 31, 2025

What MACD trends signal for Ovid Therapeutics Inc. (1OT) stockQuarterly Trade Summary & AI Forecasted Entry and Exit Points - newser.com

Oct 31, 2025
pulisher
Oct 31, 2025

Is Ovid Therapeutics Inc. (1OT) stock protected from inflation2025 Breakouts & Breakdowns & Safe Entry Zone Tips - newser.com

Oct 31, 2025
pulisher
Oct 30, 2025

How strong is Ovid Therapeutics Inc. stock balance sheetJuly 2025 Sector Moves & Stepwise Entry/Exit Trade Alerts - newser.com

Oct 30, 2025
pulisher
Oct 29, 2025

Using flow based indicators on Ovid Therapeutics Inc.Market Performance Summary & AI Driven Price Forecasts - newser.com

Oct 29, 2025
pulisher
Oct 29, 2025

Short Interest in Ovid Therapeutics (NASDAQ:OVID) Grows By 463.2% - MarketBeat

Oct 29, 2025
pulisher
Oct 28, 2025

Ovid Therapeutics (OVID) Price Target Increased by 22.06% to 4.23 - Nasdaq

Oct 28, 2025
pulisher
Oct 28, 2025

Quarterly Recap: How Ovid Therapeutics Inc. stock compares to industry benchmarksEarnings Summary Report & Weekly Sector Rotation Insights - fcp.pa.gov.br

Oct 28, 2025
pulisher
Oct 28, 2025

OVID PRE 14A: approvals for Series B conversion and warrants - Stock Titan

Oct 28, 2025
pulisher
Oct 27, 2025

OVID special meeting to approve PIPE share issuances and 315M authorization - Stock Titan

Oct 27, 2025

Ovid Therapeutics Inc (OVID) 財務データ

収益

loading

当期純利益

loading

現金流量

loading

EPS

loading
$37.54
price up icon 1.62%
$93.48
price up icon 0.96%
$28.61
price down icon 0.21%
$103.91
price down icon 0.73%
biotechnology ONC
$310.48
price up icon 0.73%
$189.60
price down icon 2.38%
大文字化:     |  ボリューム (24 時間):